正常和绝经后骨质疏松症女性的血浆雄烯二酮和雌酮水平。
Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.
作者信息
Marshall D H, Crilly R G, Nordin B E
出版信息
Br Med J. 1977 Nov 5;2(6096):1177-9. doi: 10.1136/bmj.2.6096.1177.
Abstract
Plasma androstenedione and oestrone concentrations were measured in 72 postmenopasual women. The women included some who had undergone oophorectomy, some with osteoporosis, and normal controls; they were matched for years since menopause. Both hormone concentrations were significantly reduced in the women with osteoporosis. The women who had undergone oophorectomy had hormone concentrations intermediate between the normal and osteoporotic values. Oestrogen deficiency secondary to low androstenedione levels is a major risk factor in postmenopausal osteoporosis, and may be caused by failure of ovarian stromal androgen secretion or some abnormality in the pituitary-adrenal axis.
摘要
对72名绝经后女性的血浆雄烯二酮和雌酮浓度进行了测量。这些女性包括一些接受过卵巢切除术的、一些患有骨质疏松症的以及正常对照组；根据绝经后的年限进行了匹配。骨质疏松症女性的两种激素浓度均显著降低。接受过卵巢切除术的女性激素浓度介于正常和骨质疏松症数值之间。雄烯二酮水平低导致的雌激素缺乏是绝经后骨质疏松症的主要危险因素，可能是由于卵巢基质雄激素分泌失败或垂体-肾上腺轴的某些异常所致。
相似文献
1
Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.正常和绝经后骨质疏松症女性的血浆雄烯二酮和雌酮水平。
Br Med J. 1977 Nov 5;2(6096):1177-9. doi: 10.1136/bmj.2.6096.1177.
2
The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.未经治疗和接受皮质类固醇治疗的绝经后女性血浆雄烯二酮和雌酮水平之间的关系。
Clin Endocrinol (Oxf). 1978 Nov;9(5):407-12. doi: 10.1111/j.1365-2265.1978.tb03580.x.
3
The relation between plasma androstenedione, plasma oestrone and androstenedione to oestrone conversion rates in post-menopausal women with and without fractures.有骨折和无骨折的绝经后女性血浆雄烯二酮、血浆雌酮以及雄烯二酮向雌酮转化率之间的关系。
Clin Sci Mol Med. 1978 Feb;54(2):125-31. doi: 10.1042/cs0540125.
4
Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.绝经后骨质疏松症患者胞质雌激素受体的浓度
Am J Obstet Gynecol. 1980 Feb 15;136(4):430-3. doi: 10.1016/0002-9378(80)90666-3.
5
Plasma androstenedione and oestrone levels in the climacteric syndrome.更年期综合征患者血浆雄烯二酮和雌酮水平
Maturitas. 1984 Apr;5(4):245-50. doi: 10.1016/0378-5122(84)90017-3.
6
Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.绝经后骨质疏松症的患病率、发病机制及治疗
Aust N Z J Med. 1979 Feb;9(1):24-30. doi: 10.1111/j.1445-5994.1979.tb04108.x.
7
Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women.正常、骨质疏松及接受皮质类固醇治疗的绝经后女性的激素状态。
J R Soc Med. 1978 Oct;71(10):733-6. doi: 10.1177/014107687807101006.
8
The effect of oophorectomy on plasma oestrone and androstenedione levels in the rat.卵巢切除术对大鼠血浆雌酮和雄烯二酮水平的影响。
Acta Endocrinol (Copenh). 1978 Jul;88(3):562-6. doi: 10.1530/acta.0.0880562.
9
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Maturitas. 1982 Apr;4(1):33-42. doi: 10.1016/0378-5122(82)90017-2.
10
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.老年女性的子宫切除术、卵巢切除术与内源性性激素水平：兰乔贝纳多研究
J Clin Endocrinol Metab. 2000 Feb;85(2):645-51. doi: 10.1210/jcem.85.2.6405.
引用本文的文献
1
The Association Between Heavy Metals Exposure and Sex Hormones: a Systematic Review on Current Evidence.重金属暴露与性激素之间的关系：当前证据的系统评价。
Biol Trace Elem Res. 2022 Aug;200(8):3491-3510. doi: 10.1007/s12011-021-02947-0. Epub 2021 Oct 19.
2
Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).多民族女性队列中的性激素与骨折：女性健康倡议研究（WHI）
J Clin Endocrinol Metab. 2017 May 1;102(5):1538-1547. doi: 10.1210/jc.2016-3589.
3
Sex steroids, bone turnover and bone mineral density in pre-, peri-, and postmenopausal women.绝经前、围绝经期和绝经后妇女的性激素、骨转换和骨密度。
Environ Health Prev Med. 1998 Oct;3(3):123-9. doi: 10.1007/BF02931702.
4
Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency.I型骨质疏松症是由骨骼对雌激素缺乏的反应性增强所致的证据。
Osteoporos Int. 2003 Sep;14(9):728-33. doi: 10.1007/s00198-003-1437-9. Epub 2003 Jul 18.
5
Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats.
Calcif Tissue Int. 1996 Apr;58(4):268-72. doi: 10.1007/BF02508647.
6
Dehydroepiandrosterone sulphate and bone mineral density.
Osteoporos Int. 1994 Mar;4(2):84-8. doi: 10.1007/BF01623229.
7
Treatment of spinal osteoporosis in postmenopausal women.绝经后女性脊柱骨质疏松症的治疗
Br Med J. 1980 Feb 16;280(6212):451-4. doi: 10.1136/bmj.280.6212.451.
8
Postmenopausal osteoporosis.绝经后骨质疏松症
Br Med J (Clin Res Ed). 1982;285(6342):585-8. doi: 10.1136/bmj.285.6342.585.
9
Sex steroids and bone mass. A study of changes about the time of menopause.性类固醇与骨量。一项关于绝经前后变化的研究。
J Clin Invest. 1987 Nov;80(5):1261-9. doi: 10.1172/JCI113201.
10
Bone mineral density in Addison's disease.艾迪生病患者的骨矿物质密度
Br Med J (Clin Res Ed). 1987 Jul 18;295(6591):214. doi: 10.1136/bmj.295.6591.214.
本文引用的文献
1
Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age.
J Clin Endocrinol Metab. 1974 Mar;38(3):476-9. doi: 10.1210/jcem-38-3-476.
2
The crush fracture syndrome in postmenopausal women.
Clin Endocrinol Metab. 1973 Jul;2(2):293-315. doi: 10.1016/s0300-595x(73)80045-3.
3
Post-menopausal osteopenia and osteoporosis.
Front Horm Res. 1975;3:131-49. doi: 10.1159/000398272.
4
The relationship between oestrogen status and bone loss in post-menopausal women.
Clin Endocrinol (Oxf). 1976;5 Suppl:353S-361S. doi: 10.1111/j.1365-2265.1976.tb03844.x.
5
Letter: Osteoporosis and androgens.信函：骨质疏松症与雄激素
Lancet. 1976 Jun 19;1(7973):1357. doi: 10.1016/s0140-6736(76)92703-3.
Zotero 插件